Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
1.640
-0.020 (-1.20%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Fortress Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -46 | -60.64 | -86.58 | -64.7 | -46.53 | Upgrade
|
Depreciation & Amortization | 4.46 | 6 | 7.39 | 6.79 | 5.33 | Upgrade
|
Other Amortization | 2.05 | 3.03 | 2.07 | 3.91 | 5.62 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.03 | 2.66 | 0.26 | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | 3.94 | 7.47 | 0.64 | 15.63 | 2.83 | Upgrade
|
Loss (Gain) From Sale of Investments | -0.74 | 0.76 | - | -36.45 | -6.42 | Upgrade
|
Stock-Based Compensation | 32.62 | 17.03 | 22.99 | 19.49 | 13.47 | Upgrade
|
Provision & Write-off of Bad Debts | 0.52 | 0.44 | 0.28 | 0.05 | 0.05 | Upgrade
|
Other Operating Activities | -68.95 | -92.45 | -125.73 | -97.63 | -53.26 | Upgrade
|
Change in Accounts Receivable | 4.48 | 12.55 | -5.38 | 0.77 | -10.44 | Upgrade
|
Change in Inventory | -4.23 | 3.95 | 1.74 | -8.46 | -0.55 | Upgrade
|
Change in Accounts Payable | -6.39 | -24.38 | 8.35 | 43.31 | 11.1 | Upgrade
|
Change in Unearned Revenue | - | - | -1.88 | 2.61 | - | Upgrade
|
Change in Income Taxes | 0.09 | 0.12 | 0.38 | 0.35 | 0.14 | Upgrade
|
Change in Other Net Operating Assets | -2.08 | -4.76 | -3.92 | -2.2 | -5.03 | Upgrade
|
Operating Cash Flow | -80.19 | -128.23 | -179.4 | -116.54 | -83.68 | Upgrade
|
Capital Expenditures | - | -0.06 | -2.72 | -4.57 | -1.93 | Upgrade
|
Sale of Property, Plant & Equipment | - | 6 | 0.13 | - | - | Upgrade
|
Divestitures | - | - | - | 56.86 | - | Upgrade
|
Sale (Purchase) of Intangibles | -15 | -8.04 | -20.34 | -11.78 | -5.24 | Upgrade
|
Other Investing Activities | - | -0.01 | - | - | - | Upgrade
|
Investing Cash Flow | -15 | -2.1 | -22.93 | 40.51 | -7.16 | Upgrade
|
Short-Term Debt Issued | - | 28 | 5 | 7 | - | Upgrade
|
Long-Term Debt Issued | 43.67 | 14.53 | 47.11 | - | 60 | Upgrade
|
Total Debt Issued | 43.67 | 42.53 | 52.11 | 7 | 60 | Upgrade
|
Short-Term Debt Repaid | - | -30.95 | -2.86 | -6.19 | - | Upgrade
|
Long-Term Debt Repaid | -1.25 | -51.38 | -5 | -15.75 | -90.17 | Upgrade
|
Total Debt Repaid | -1.25 | -82.32 | -7.86 | -21.94 | -90.17 | Upgrade
|
Net Debt Issued (Repaid) | 42.42 | -39.79 | 44.25 | -14.94 | -30.17 | Upgrade
|
Issuance of Common Stock | 22.23 | 24.8 | 6.72 | 9.37 | 46.13 | Upgrade
|
Repurchase of Common Stock | - | - | -1.7 | - | -0.07 | Upgrade
|
Preferred Dividends Paid | -4.02 | -8.03 | -8.03 | -8.03 | -6.52 | Upgrade
|
Dividends Paid | -4.02 | -8.03 | -8.03 | -8.03 | -6.52 | Upgrade
|
Other Financing Activities | 10.01 | 56.17 | 34.17 | 162.59 | 123.96 | Upgrade
|
Financing Cash Flow | 70.64 | 32.74 | 75.32 | 148.99 | 172.41 | Upgrade
|
Net Cash Flow | -24.55 | -97.59 | -127.01 | 72.97 | 81.56 | Upgrade
|
Free Cash Flow | -80.19 | -128.29 | -182.12 | -121.11 | -85.61 | Upgrade
|
Free Cash Flow Margin | -139.04% | -151.80% | -240.44% | -176.05% | -187.74% | Upgrade
|
Free Cash Flow Per Share | -3.86 | -15.82 | -30.74 | -22.23 | -17.83 | Upgrade
|
Cash Interest Paid | 7.16 | 7.95 | 9.42 | 6.92 | 8.82 | Upgrade
|
Cash Income Tax Paid | 0.12 | -0.06 | 0.86 | 0.99 | - | Upgrade
|
Levered Free Cash Flow | -53.01 | -98.15 | -118.4 | -67.29 | -55.83 | Upgrade
|
Unlevered Free Cash Flow | -46.6 | -91.62 | -111.94 | -61.64 | -51.87 | Upgrade
|
Change in Net Working Capital | 4.32 | 21.51 | -7.97 | -40.31 | 4.63 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.